Bone oedema on MRI is highly associated with low bone mineral density in patients with early inflammatory back pain: Results from the DESIR cohort

Annals of the Rheumatic Diseases

Volumn 72, Issue 12, 2013, Pages 1914-1919

  Briot, Karine ^a   Durnez, Anne ^a,b   Paternotte, Simon ^a   Miceli Richard, Corinne ^c   Dougados, Maxime ^a   Roux, Christian ^a  

^a Paris Descartes University ^*  (France)

^b AZ GROENINGE   (Belgium)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE; ARTICLE; BACKACHE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BODY COMPOSITION; BONE DENSITY; BONE LESION; BONE MARROW EDEMA; CLINICAL ASSESSMENT; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATORY BACK PAIN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SPONDYLARTHRITIS;

BONE MINERAL DENSITY; OSTEOPOROSIS; SPONDYLOARTHRITIS;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADULT; BACK PAIN; BLOOD SEDIMENTATION; BONE DENSITY; BONE DISEASES; C-REACTIVE PROTEIN; COHORT STUDIES; EDEMA; FEMALE; FRANCE; HIP JOINT; HUMANS; LUMBAR VERTEBRAE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OSTEOPOROSIS; RISK FACTORS; SPONDYLARTHRITIS; YOUNG ADULT;

EID: 84887456766     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-201845     Document Type: Article

References (40)

1. Calin A. Osteoporosis and ankylosing spondylitis. Br J Rheumatol 1991;30:318-19.
2. Baek HJ, Kang SW, Lee YJ, et al. Osteopenia in men with mild and severe ankylosing spondylitis. Rheumatol Int 2005;26:30-4.
3. El Maghraoui A, Borderie D, Cherruau B, et al. Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 1999;26:2205-9.
4. Roux C. Osteoporosis in inflammatory joint diseases. Osteoporos Int 2011;22:421-33.
5. Cooper C, Carbone L, Michet CJ, et al. Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol 1994;21:1877-82.
6. Will R, Palmer R, Bhalla AK, et al. Osteoporosis in early ankylosing spondylitis. A primary pathological event? Lancet 1989; ii: 1483-5.
7. Toussirot E, Michel F, Wendling D. Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology 2001;40:882-8.
8. El Maghraoui A, Borderie D, Edouard R, et al. Osteoporosis, body composition and bone turnover in ankylosing spondylitis. J Rheumatol 1999;26:2205-9.
9. Ghozlani I, Ghazi M, Nouijai A, et al. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone 2009;44:772-6.
10. Maillefert JF, Aho S, El Maghraoui A, et al. Changes in bone density in patients with ankylosing spondylitis: a 2 year follow-up study. Osteoporosis Int 2001;12:605-9.
11. Gratacos J, Collado A, Pons F, et al. Significant loss of bone mass in patients with early, active ankylosing spondylitis. A follow-up study. Arthritis Rheum 1999;42:2319-24.
12. Vosse D, Landewé R, Van Der Heijde D, et al. Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study. Ann Rheum Dis 2009;68:1839-42.
13. Geusens P, Vosse D, Van Der Heijde DM, et al. High prevalence of thoracic vertebral deformities and discal wedging in ankylosing spondylitis patients with hyperkyphosis. J Rheumatol 2001;28:1856-61.
14. Mitra D, Elvins DM, Speden DJ, et al. The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. Rheumatology 2000;39:85-9.
15. Dougados M, D'Agostino MA, Benessiano J, et al. The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: Study design and baseline characteristics of the 708 recruited patients. Joint Bone Spine 2011;78:598-603.
16. Calin A, Porta J, Fries JF, et al. Clinical history as a screening test for ankylosing spondylitis. JAMA 1977;237:2613-14.
17. Rudwaleit M, Metter A, Listing J, et al. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum 2006;54:569-78.
18. Van Der Heijde D, Lie E, Kvien TK, et al. ASDAS, a highly discriminatory ASAS endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68:1811-8.
19. Arverns HL, Oxtoby J, Taylor HG, et al. Radiological outcome in ankylosing spondylitis: use of the Ankylosing Spine Score (SASSS). Br J Rheumatol 1996;35:373-6.
20. Rudwaleit M, Van Der Heijde D, Landewé R, et al. The development of Assessment of Spondylarthritis International Society (ASAS) classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:770-6.
21. Lewiecki EM, Gordon CM, Baim S, et al. Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry. Osteoporos Int 2008;19:1369-78.
22. Donnelly S, Doyle DV, Denton A, et al. Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 1994;53:117-21.
23. Karberg K, Zochling J, Sieper J, et al. Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol 2005;32:1290-8.
24. Van Der Weijden MA, Van Denderen JC, Lems WF, et al. Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies. Clin Rheumatol 2011;30:497-503.
25. Franck H, Meurer T, Hofbauer LC. Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis. J Rheumatol 2004;31:2236-41.
26. Giltay EJ, Popp-Snijders C, Van SD, et al. Serum testosterone levels are not elevated in patients with ankylosing spondylitis. J Rheumatol 1998;25:2389-94.
27. Giltay EJ, Van SD, Gooren LJ, et al. Androgens and ankylosing spondylitis: a role in the pathogenesis?. Ann NY Acad Sci 1999;876:340-64.
28. Rudwaleit M, Haibel H, Baraliakos X, et al. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 2009;60:717-27.
29. Heuft-Dorenbosch L, Landewé R, Weijers R, et al. Performance of various criteria sets in patients with inflammatory back pain of short duration; the Maastricht early spondyloarthritis clinic. Ann Rheum Dis 2007;66:92-8.
30. Haugeberg G, Bennett AN, McGonagle D, et al. Bone loss in very early inflammatory back pain in undifferentiated spondyloarthropathy: a 1-year observational study. Ann Rheum Dis 2010;69:1364-6.
31. Briot K, Garnero P, Le Henanff A, et al. Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor {alpha} treatment. Ann Rheum Dis 2005;64:1137-40.
32. Briot K, Gossec L, Kolta S, et al. Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment. J Rheumatol 2008;35:855-61.
33. Marzo-Ortega H, McGonagle D, Haugeberg G, et al. Bone mineral density improvement in spondyloarthropathy after treatment with etanercept. Ann Rheum Dis 2003;62:1020-1.
34. Marzo-Ortega H, McGonagle D, Jarrett S, et al. Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study. Ann Rheum Dis 2005;64:1568-75.
35. Visvanathan S, Van Der Heijde D, Deodhar A, et al. Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68:175-82.
36. Bennett AN, McGonagle D, O'Connor P, et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 2008;58:3413-18.
37. Jevtic V, Kos-Golja M, Rozman B, et al. Marginal erosive discovertebral "Romanus" lesions in ankylosing spondylitis demonstrated by contrast enhanced Gd-DTPA magnetic resonance imaging. Skeletal Radiol 2000;29:27-33.
38. Appel H, Loddenkemper C, Grozdanovic Z, et al. Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther 2006;8:R143.
39. Bollow M, Fischer T, Reisshauer H, et al. Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis-cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann Rheum Dis 2000;59:135-40.
40. Jimenez-Boj E, Nöbauer-Huhmann I, Hanslik-Schnabel B, et al. Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum 2007;56:1118-24.